We don't. However, one of the slides with the CC showed that no other I-O regimen (including those with INCY's Epacadostat plus a PD-1 drug) has produced a 30% ORR (or anything close to that) in this patient population.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.